New test aims to Fine-Tune heart medication, reduce bleeding risk
NCT ID NCT06216821
Summary
This study is testing if a new risk score can help doctors decide the best time to reduce the intensity of blood-thinning therapy for patients who had a heart attack and received a stent. About 3,500 participants will be assigned to have their medication adjusted either after 1 month or 3 months based on their personal risk score. The goal is to find the safest balance between preventing future clots and avoiding serious bleeding complications.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
General Hospital of Northern Theater Command
RECRUITINGShenyang, Liaoning, 110016, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.